SCHEMBL6948374

SCHEMBL6948374

O=C1c2ccccc2C(=O)N1CC(Cc1cc[c]cc1)(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.45
PTPRC P08575 1/20 0.45
MAPK1 P28482 1/20 0.40
CTRB1 P17538 1/20 0.40
RAB9A P51151 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948131 0.81 PTPN1 (0.74) PTPN1PTPRC
SCHEMBL7215479 0.79 PTPN1 (0.46) PTPN1PTPRCMAPK1CTRB1RAB9A
SCHEMBL6578349 0.78 TDP1 (0.46) PTPN1PTPRCMAPK1RAB9AKMT2A
SCHEMBL6948365 0.78 PTPN1 (0.49) PTPN1PTPRCMAPK1CTRB1RAB9A
SCHEMBL7888225 0.73 PTPN1 (0.57) PTPN1PTPRCKMT2A
SCHEMBL1555294 0.72 PTPN1 (0.61) PTPN1PTPRCMAPK1RAB9AKMT2A
SCHEMBL9010635 0.72 RAB9A (0.42) MAPK1CTRB1RAB9ACYP3A4CYP2D6
SCHEMBL20083679 0.69 ALDH1A1 (0.63) MAPK1CTRB1KMT2AMEN1ALDH1A1
SCHEMBL27650816 0.68 TDP1 (0.46) MAPK1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL6723702 0.68 RAB9A (0.46) MAPK1CTRB1RAB9ACYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115729-B1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B MERCK FROSST CANADA INC (CA) 2003-02-19 EP disclosed
US-6174874-B1 ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE MERCK FROSST CANADA & CO. (CA) 2001-01-16 US disclosed